MedTrace Logo

Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)

NCT00869336 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2011-06-21

No results posted yet for this study

Summary

To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.

Conditions

  • Tinea Pedis

Interventions

DRUG

Luliconazole Cream 1% - 2 wks

Topical cream applied daily for 2 weeks

DRUG

Placebo Comparator -2 wks

Placebo cream applied daily for 2 weeks

DRUG

Luliconazole Cream 1% - 4 wks

Topical cream applied daily for 4 weeks

DRUG

Placebo Comparator - 4 wks

Placebo cream applied daily for 4 weeks

Sponsors & Collaborators

  • Tinea Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00869336 on ClinicalTrials.gov